Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Map-dot-fingerprint Dystrophy Medication

  • Author: David Verdier, MD; Chief Editor: Hampton Roy, Sr, MD  more...
 
Updated: Jun 16, 2016
 

Medication Summary

The goals of pharmacotherapy are to reduce morbidity and to prevent complications.

Next

Hyperosmolar agents

Class Summary

Create osmotic gradient that draws water out of the cornea.

Sodium chloride hypertonic, ophthalmic (Muro 128, AK-NaCl)

 

Used for temporary relief of corneal edema. May improve corneal epithelial adhesion and irregular corneal astigmatism.

Previous
 
 
Contributor Information and Disclosures
Author

David Verdier, MD Clinical Professor, Department of Surgery, Division of Ophthalmology, Michigan State University College of Human Medicine

David Verdier, MD is a member of the following medical societies: American Academy of Ophthalmology, Michigan State Medical Society, Michigan Society of Eye Physicians & Surgeons, Cornea Society, American Medical Association, Eye Bank Association of America

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Christopher J Rapuano, MD Professor, Department of Ophthalmology, Jefferson Medical College of Thomas Jefferson University; Director of the Cornea Service, Co-Director of Refractive Surgery Department, Wills Eye Hospital

Christopher J Rapuano, MD is a member of the following medical societies: American Academy of Ophthalmology, American Ophthalmological Society, American Society of Cataract and Refractive Surgery, Contact Lens Association of Ophthalmologists, International Society of Refractive Surgery, Cornea Society, Eye Bank Association of America

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Cornea Society, Allergan, Bausch & Lomb, Bio-Tissue, Shire, TearScience, TearLab<br/>Serve(d) as a speaker or a member of a speakers bureau for: Allergan, Bausch & Lomb, Bio-Tissue, TearScience.

Chief Editor

Hampton Roy, Sr, MD Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences

Hampton Roy, Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, Pan-American Association of Ophthalmology

Disclosure: Nothing to disclose.

Additional Contributors

Fernando H Murillo-Lopez, MD Senior Surgeon, Unidad Privada de Oftalmologia CEMES

Fernando H Murillo-Lopez, MD is a member of the following medical societies: American Academy of Ophthalmology

Disclosure: Nothing to disclose.

References
  1. Cogan DG, Donaldson DD, Kuwabara T, et al. Microcystic dystrophy of the corneal epithelium. Trans Am Ophthalmol Soc. 1964. 62:213-25. [Medline].

  2. Cogan DG, Kuwabara T, Donaldson DD, et al. Microcystic dystrophy of the cornea. A partial explanation for its pathogenesis. Arch Ophthalmol. 1974 Dec. 92(6):470-4. [Medline].

  3. Guerry D 3rd. Observations on Cogan's microcystic dystrophy of the corneal epithelium. Trans Am Ophthalmol Soc. 1965. 63:320-34. [Medline].

  4. Waring GO 3rd, Rodrigues MM, Laibson PR. Corneal dystrophies. I. Dystrophies of the epithelium, Bowman's layer and stroma. Surv Ophthalmol. 1978 Sep-Oct. 23(2):71-122. [Medline].

  5. Trobe JD, Laibson PR. Dystrophic changes in the anterior cornea. Arch Ophthalmol. 1972 Apr. 87(4):378-82. [Medline].

  6. Laibson PR, Krachmer JH. Familial occurrence of dot (microcystic), map, fingerprint dystrophy of the cornea. Invest Ophthalmol. 1975 May. 14(5):397-9. [Medline].

  7. Rodrigues MM, Fine BS, Laibson PR, et al. Disorders of the corneal epithelium. A clinicopathologic study of dot, geographic, and fingerprint patterns. Arch Ophthalmol. 1974 Dec. 92(6):475-82. [Medline].

  8. Weiss JS, Moller HU, Aldave AJ, Seitz B, et al. IC3D classification of corneal dystrophies--edition 2. Cornea. 2015. 34(2):117-159.

  9. Boutboul S, Black GC, Moore JE, et al. A subset of patients with epithelial basement membrane corneal dystrophy have mutations in TGFBI/BIGH3. Hum Mutat. 2006 Jun. 27(6):553-7. [Medline].

  10. Paliwal P, Sharma A, Tandon R, Sharma N, Titiyal JS, Sen S, et al. TGFBI mutation screening and genotype-phenotype correlation in north Indian patients with corneal dystrophies. Mol Vis. 2010 Jul 29. 16:1429-38. [Medline]. [Full Text].

  11. Werblin TP, Hirst LW, Stark WJ, et al. Prevalence of map-dot-fingerprint changes in the cornea. Br J Ophthalmol. 1981 Jun. 65(6):401-9. [Medline].

  12. Reidy JJ, Paulus MP, Gona S. Recurrent erosions of the cornea: epidemiology and treatment. Cornea. 2000 Nov. 19(6):767-71. [Medline].

  13. Brown N, Bron A. Recurrent erosion of the cornea. Br J Ophthalmol. 1976 Feb. 60 (2):84-96. [Medline].

  14. Guerry D III. Fingerprint-like lines in the cornea. Am J Ophthalmol. 1950. 33:724-726.

  15. Akhtar S, Bron AJ, Meek KM, et al. Clinical and ultrastructural findings in mare's tail lines of the corneal epithelium. Br J Ophthalmol. 2004 Jul. 88(7):864-7. [Medline].

  16. Seitz B, Lisch W. Stage-related therapy of corneal dystrophies. Dev Ophthalmol. 2011. 48:116-53. [Medline].

  17. Buxton JN, Constad WH. Superficial epithelial keratectomy in the treatment of epithelial basement membrane dystrophy. Cornea. 1987. 6(4):292-7. [Medline].

  18. Itty S, Hamilton SS, Baratz KH, et al. Outcomes of epithelial debridement for anterior basement membrane dystrophy. Am J Ophthalmol. 2007 Aug. 144(2):217-221. [Medline].

  19. Forstot SL, et al. Diamond burr keratectomy for the treatment of recurrent corneal erosion syndrome. Ophthalmol Suppl: Poster. 1994.

  20. Soong HK, Farjo Q, Meyer RF, et al. Diamond burr superficial keratectomy for recurrent corneal erosions. Br J Ophthalmol. 2002 Mar. 86(3):296-8. [Medline].

  21. Ohman L, Fagerholm P, Tengroth B. Treatment of recurrent corneal erosions with the excimer laser. Acta Ophthalmol (Copenh). 1994 Aug. 72(4):461-3. [Medline].

  22. Orndahl MJ, Fagerholm PP. Phototherapeutic keratectomy for map-dot-fingerprint corneal dystrophy. Cornea. 1998 Nov. 17(6):595-9. [Medline].

  23. Sridhar MS, Rapuano CJ, Cosar CB, et al. Phototherapeutic keratectomy versus diamond burr polishing of Bowman's membrane in the treatment of recurrent corneal erosions associated with anterior basement membrane dystrophy. Ophthalmology. 2002 Apr. 109(4):674-9. [Medline].

  24. Pogorelov P, Langenbucher A, Kruse F, Seitz B. Long-term results of phototherapeutic keratectomy for corneal map-dot-fingerprint dystrophy (Cogan-Guerry). Cornea. 2006 Aug. 25 (7):774-7. [Medline].

  25. McLean EN, MacRae SM, Rich LF. Recurrent erosion. Treatment by anterior stromal puncture. Ophthalmology. 1986 Jun. 93(6):784-8. [Medline].

  26. Dastgheib KA, Clinch TE, Manche EE, et al. Sloughing of corneal epithelium and wound healing complications associated with laser in situ keratomileusis in patients with epithelial basement membrane dystrophy. Am J Ophthalmol. 2000 Sep. 130(3):297-303. [Medline].

  27. Rezende RA, Uchoa UC, Cohen EJ, et al. Complications associated with anterior basement membrane dystrophy after laser in situ keratomileusis. J Cataract Refract Surg. 2004 Nov. 30(11):2328-31. [Medline].

  28. Kenyon KR, Paz H, Greiner JV, et al. Corneal epithelial adhesion abnormalities associated with LASIK. Ophthalmology. 2004 Jan. 111(1):11-7. [Medline].

Previous
Next
 
Corneal maps. Best seen with broad illumination beam.
Corneal dots. Cluster of corneal dots.
Corneal fingerprints. Best seen in retroillumination.
Pseudofingerprints (shift lines) in a patient with Fuchs corneal dystrophy.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.